Mostrar el registro sencillo

dc.contributor.authorVilanova Urdaniz, Iosune
dc.contributor.authorHernández Hernández, José Luis 
dc.contributor.authorMata Arnaiz, María Cristina
dc.contributor.authorDurán, C
dc.contributor.authorGarcía Unzueta, María Teresa 
dc.contributor.authorPortilla González, Virginia
dc.contributor.authorFuentevilla Rodríguez, Patricia
dc.contributor.authorCorrales Martínez, Alfonso
dc.contributor.authorGonzález Vela, María del Carmen 
dc.contributor.authorGonzález-Gay Mantecón, Miguel Ángel 
dc.contributor.authorBlanco Alonso, Ricardo 
dc.contributor.authorGonzález López, Marcos Antonio 
dc.contributor.otherUniversidad de Cantabriaes_ES
dc.date.accessioned2019-04-11T09:05:50Z
dc.date.available2019-06-01T02:45:13Z
dc.date.issued2018-05
dc.identifier.issn0926-9959
dc.identifier.issn1468-3083
dc.identifier.urihttp://hdl.handle.net/10902/16148
dc.description.abstractBackground: The association between chronic inflammatory diseases, such as rheumatoid arthritis and psoriasis, and insulin resistance (IR) has been well established. Hidradenitis suppurativa (HS) is a chronic inflammatory cutaneous disease that affects the apocrine glandbearing areas of the body. Objective: We aimed to determine the prevalence of IR in patients with HS. Methods: This cross-sectional, case-control study enrolled 137 subjects, 76 patients with HS and 61 age- and gender-matched controls. Demographic data, clinical examination of HS patients, anthropometric measures, cardiovascular risk factors and laboratory studies were recorded. The homeostasis model assessment of IR (HOMA-IR) was calculated in all participants by measuring fasting plasma glucose and insulin levels. Results: The median (IQR) HOMA-IR value in HS patients was significantly higher [2.0 (1.0-3.6)] than in controls [1.5(0.9-2.3)] (p=0.01). The prevalence of IR was significantly higher in cases (43.4%) compared with controls (16.4%) (p=0.001). In the linear regression multivariable analysis after adjusting for age, sex and body mass index (BMI), HS remained as a significant factor for a higher HOMA-IR [2.51(0.18) vs 1.92(0.21); p=0.04]. The HOMA-IR value and the prevalence of IR did not differ significantly among HS patients grouped by severity of the disease. Conclusion: Our results show an increased frequency of IR in HS. Thus, we suggest HS patients to be evaluated for IR and managed accordingly.es_ES
dc.format.extent19 p.es_ES
dc.language.isoenges_ES
dc.publisherWileyes_ES
dc.rights© European Academy of Dermatology and Venereology. Published by Wiley. This is the peer reviewed version of the following article: Insulin resistance in hidradenitis suppurativa: a case-control study, which has been published in final form at https://doi.org/10.1111/jdv.14894. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving.es_ES
dc.sourceJ Eur Acad Dermatol Venereol. 2018 May;32(5):820-824es_ES
dc.titleInsulin resistance in hidradenitis suppurativa: a case-control studyes_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.rights.accessRightsopenAccesses_ES
dc.identifier.DOI10.1111/jdv.14894
dc.type.versionacceptedVersiones_ES


Ficheros en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo